Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-64D (IGHV3-64D) is a gene coding for one of the variable (V) regions of immunoglobulin heavy chains, essential for the generation of antibody diversity[1][4]. It encodes part of the variable domain that participates in antigen recognition and binding, a critical determinant of the adaptive immune response conducted by B lymphocytes. The IGHV3-64D gene contributes to the V(D)J recombination process, which creates the vast repertoire of immunoglobulin specificities by shuffling variable (V), diversity (D), and joining (J) gene segments. The product is not itself a receptor, enzyme, transporter, or classical therapeutic target but rather an intrinsic part of immunoglobulin structure. Dysregulation or mutation of IGHV genes, including IGHV3-64D, can be implicated in various B cell lymphoproliferative disorders and autoimmune diseases through the selection of aberrant or autoreactive antibodies[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-64D (IGHV3-64D).